Treace Medical Concepts (TMCI) Non-Current Assets (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Non-Current Assets came in at $60.6 million in Q2 2026, up 2.99% on a YoY basis from $58.8 million in Q2 2025, and little changed quarter-over-quarter from $60.6 million in Q1 2026.
Analysis
Treace Medical Concepts (TMCI) Non-Current Assets (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has reported Non-Current Assets for 7 consecutive years, with $60.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets rose 2.99% year-over-year to $60.6 million; the trailing twelve-month figure through Jun 2026 stood at $238.4 million (up 5.34% YoY), and the FY2025 full-year result was $58.5 million, up 5.09% from the prior year.
- Non-Current Assets held at $60.6 million in Q2 2026 per TMCI's latest filing, from $60.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $60.6 million in Q1 2026 and bottomed at $19.2 million in Q1 2022.
- Historically, Non-Current Assets has averaged $47.5 million across 5 years, with a median of $54.9 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 1966.63% in 2022, then climbed 1.95% in 2025.
- Over 5 years, Non-Current Assets stood at $25.6 million in 2022, then surged by 108.99% to $53.5 million in 2023, then gained by 4.0% to $55.7 million in 2024, then advanced by 5.09% to $58.5 million in 2025, then climbed by 3.54% to $60.6 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $60.6 million, $60.6 million, and $58.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Treace Medical Concepts | 294.68 Mn | 249.06 Mn | 35.61 Mn | 60.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60.60 Mn |
| Mar 31, 2026 | 60.63 Mn |
| Dec 31, 2025 | 58.53 Mn |
| Sep 30, 2025 | 58.59 Mn |
| Jun 30, 2025 | 58.84 Mn |
| Mar 31, 2025 | 56.41 Mn |
| Dec 31, 2024 | 55.69 Mn |
| Sep 30, 2024 | 55.32 Mn |
| Jun 30, 2024 | 54.53 Mn |
| Mar 31, 2024 | 55.33 Mn |
| Dec 31, 2023 | 53.55 Mn |
| Sep 30, 2023 | 53.22 Mn |
| Jun 30, 2023 | 51.55 Mn |
| Mar 31, 2023 | 26.04 Mn |
| Dec 31, 2022 | 25.62 Mn |
| Sep 30, 2022 | 28.54 Mn |
| Jun 30, 2022 | 23.53 Mn |
| Mar 31, 2022 | 19.20 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 2.23 Mn |